Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase Ⅲ randomized clinical trial

著录项

• 来源
  《Neuro-oncology》 |2023年第2期|339-350|共12页
• 作者

  Andrew B. Lassman; Stephanie L. Pugh; Tony J. C. WangKenneth AldapeHui K. GanMatthias PreusserMichael A. VogelbaumErik P. SulmanMinhee WonPeixin ZhangGolnaz MoazamiMarian S. MacsaiMark R. GilbertEarle E. BainVincent BlotPeter J. AnsellSuva jit SamantaMadan G. KunduTerri S. ArmstrongJeffrey S. WefelClemens SeidelFilip Y. de VosSigmund HsuAndres F. CardonaGiuseppe LombardiDmitry BentsionRichard A. PetersonCraig GedyeVeronique BourgAntje WickWalter J. CurranMinesh P. Mehta;

  展开▼
• 作者单位

  Abbvie, Inc., North Chicago, Illinois, USA;

  Abbvie, Inc., North Chicago, Illinois, USA , Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA;

  Neuro-Oncology BranchDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USADepartment of Radiation-Oncology, University Hospital Leipzig, Leipzig, GermanyUniversity Medical Center Utrecht, Cancer Center, Utrecht, The NetherlandsDepartment of Neurosurgery, University of Texas Health Sciences Center, McGovern School of Medicine, Houston, Texas, USAFoundation for Clinical and Applied Cancer Research-FICMAC/Clinical andTranslational Oncology Group, BrainTumor Section, Bogota, Colombia, Luis Carlos Sarmiento Angulo CancerTreatment and Research Center - CITC, Bogota, ColombiaDepartment of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, ItalySverdlovsk Regional Oncology Center, Ekaterinburg, RussiaMetro Minnesota NCORP, Saint Paul, Minnesota, USACalvary Mater Newcastle, Waratah, New South Wales, AustraliaDepartment of Neurology, Cote dAzur University, Nice, FranceHeidelberg University Medical Center, Heidelberg, GermanyWinship Cancer Institute, Emory University, Atlanta, Georgia, USA , GenesisCare, Sydney, AustraliaMiami Cancer Institute, Baptist Hospital, Miami, Florida, USADivision of Neuro-Oncology , Departments of Neurology, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Hospital, NewYork, NewYork, USA, Herbert Irving Comprehensive Cancer Center, NewYork, NewYork, USARTOG Foundation Statistics and Data Management Center, American College of Radiology, Philadelphia, PennsylvaniaRadiation Oncology (in Neurological Surgery), Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Hospital, NewYork, NewYork, USA, Herbert Irving Comprehensive Cancer Center, NewYork, NewYork, USALaboratory of PathologyNational Cancer Institute, Bethesda, Maryland, USA , CancerTherapies and Biology Group, Centre of Research Excellence in Brain Tumours, Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, Heidelberg, Melbourne, Australia , LaTrobe UniDepartment of Medicine Ⅰ, Division of Oncology, Medical University of Vienna, Vienna, AustriaDepartment of Neuro-Oncology, Moffitt Cancer Center, Tampa, FloridaDepartment of Radiation Oncology, NewYork University, Grossman School of Medicine, NewYork, NewYork, USA, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, NewYork, NewYork, USARTOG Foundation Statistics and Data Management Center, American College of Radiology, Philadelphia, Pennsylvania, Incyte Corp., Wilmington, Delaware, USAOphthalmology, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Hospital, NewYork, NewYork, USANorthShore University HealthSystem, Department of Ophthalmology, University of Chicago Pritzker School of Medicine, Evanston, Illinois, USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 英语
• 中图分类
• 关键词

  antibody drug conjugate; EGFR; depatuxizumab mafodotin; glioblastoma; phase Ⅲ;